These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 4202631

  • 1. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F, Lacava V, Fiorilli M, Ciarla MV.
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract] [Full Text] [Related]

  • 2. Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.
    Piessens WF, Schur PH, Moloney WC, Churchill WH.
    N Engl J Med; 1973 Jan 25; 288(4):176-80. PubMed ID: 4629847
    [No Abstract] [Full Text] [Related]

  • 3. Rosette-forming lymphocytes in normals and patients with malignant lymphomas.
    Cohnen G, Augener W, Buka A, Brittinger G.
    Acta Haematol; 1974 Jan 25; 51(2):65-75. PubMed ID: 4217078
    [No Abstract] [Full Text] [Related]

  • 4. B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.
    Seligmann M, Preud'Homme JL, Brouet JC.
    Transplant Rev; 1973 Jan 25; 16():85-113. PubMed ID: 4204588
    [No Abstract] [Full Text] [Related]

  • 5. Serum immunoglobulin E levels in patients with neoplastic disease.
    Waldmann TA, Bull JM, Bruce RM, Broder S, Jost MC, Balestra ST, Suer ME.
    J Immunol; 1974 Jul 25; 113(1):379-86. PubMed ID: 4208923
    [No Abstract] [Full Text] [Related]

  • 6. Surface IgD in immunoproliferative disorders.
    Preud'homme JL, Brouet JC, Clauvel JP, Seligmann M.
    Scand J Immunol; 1974 Jul 25; 3(6):853-8. PubMed ID: 4218365
    [No Abstract] [Full Text] [Related]

  • 7. [Immunological aspects of malignant lymphoproliferative diseases].
    Rivero I, Diumenjo M.
    Rev Clin Esp; 1977 Mar 31; 144(6):403-9. PubMed ID: 140441
    [No Abstract] [Full Text] [Related]

  • 8. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E.
    Rinsho Ketsueki; 1976 Jun 31; 17(6):600-17. PubMed ID: 823349
    [No Abstract] [Full Text] [Related]

  • 9. B-lymphoproliferative disorders: a proposed unified pathogenetic pathway.
    Ezdinli EZ, Nanus DM.
    Hematol Oncol; 1983 Jun 31; 1(4):297-319. PubMed ID: 6429025
    [Abstract] [Full Text] [Related]

  • 10. B and T lymphocyte subpopulations in human peripheral blood.
    Haegert DG, Hallberg T, Coombs RR.
    Int Arch Allergy Appl Immunol; 1974 Jun 31; 46(4):525-38. PubMed ID: 4206591
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunoglobulin E in patients with chronic lymphocytic leukaemia, multiple myeloma and morbus Waldenström (author's transl)].
    Schwarz S, Gabl F, Pastner D, Huber H, Braunsteiner H.
    Z Immunitatsforsch Exp Klin Immunol; 1974 Dec 31; 148(3):196-207. PubMed ID: 4283033
    [No Abstract] [Full Text] [Related]

  • 13. Lymphocytes bearing B- and T-cell markers in patient with lymphosarcoma cell leukemia.
    Hsu CC, Marti GE, Schrek R, Williams RC.
    Clin Immunol Immunopathol; 1975 Jan 31; 3(3):385-95. PubMed ID: 803233
    [No Abstract] [Full Text] [Related]

  • 14. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S, Good RA.
    Pol Arch Med Wewn; 1977 Feb 31; 57(2):149-72. PubMed ID: 403513
    [No Abstract] [Full Text] [Related]

  • 15. Immunological characterization of lymphocytes in lymphoproliferative diseases. Restriction of classes, subclasses, and Gm allotypes of membrane-bound Ig.
    Froland SS, Natvig JB, Stavem P.
    Scand J Immunol; 1972 Feb 31; 1(4):351-60. PubMed ID: 4590280
    [No Abstract] [Full Text] [Related]

  • 16. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
    Cohnen G, Augener W, Douglas SD, König E, Brittinger G.
    Boll Ist Sieroter Milan; 1974 Feb 31; 53(1):suppl:295. PubMed ID: 4605188
    [No Abstract] [Full Text] [Related]

  • 17. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G, Petrini MT, Tognella S, Grifoni V.
    Boll Soc Ital Biol Sper; 1972 Jul 30; 48(14):381-5. PubMed ID: 4628299
    [No Abstract] [Full Text] [Related]

  • 18. Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis.
    Knapp W, Schuit HR, Bolhuis RL, Hijmans W.
    Clin Exp Immunol; 1974 Apr 30; 16(4):541-52. PubMed ID: 4219765
    [Abstract] [Full Text] [Related]

  • 19. Combined T and B lymphocyte marker test in lymphoproliferative disorders.
    Chapel HM, Ling NR.
    Br J Haematol; 1977 Mar 30; 35(3):367-71. PubMed ID: 403927
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte membrane markers in acute lymphoblastic leukaemia.
    Aiuti F, Papa G, Lacava V, Ciarla MV, D'Amelio R, Garofalo J.
    Br J Haematol; 1974 Aug 30; 27(4):635-41. PubMed ID: 4547490
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.